Challenges With Classifying and Treating Skin and Soft Tissue Infections
JAN 16, 2017 | CONTAGION EDITORIAL STAFF
Michael D. Nailor, PharmD, BCPS-AQ ID, clinical associate professor at the University of Connecticut School of Pharmacy, clinical specialist in infectious diseases at Hartford Hospital, and director of Infectious Disease Residency program at Hartford Hospital, discusses the biggest challenges associated with classifying and treating skin and soft tissue infections.
Interview Transcript (slightly modified for readability)
“As I mentioned before, there [are] a lot of different diagnoses that go into this, and the pathogenesis of the infection itself. If you have a trauma versus a person [who] develops spontaneous cellulitis, it makes classifying it more difficult.
The difficulty with the classification is the prognostic value of it, in terms of, how long do we have to treat everybody? Do people with cellulitis need to get treated [for] longer or shorter durations than [those with] abscesses? In the past, most trials have combined all these together. Certainly when you look at the FDA guidance for doing skin and soft tissue infection trials for new antibacterials coming to the market, they’re often, sort of a hodgepodge of different infections being [brought] together, and it doesn’t really describe to us how we [can] actually treat each one of these different types of infections individually.”
To stay informed on the latest in infectious disease news and developments, please sign upfor our weekly newsletter.
Contagion® is a fully integrated news resource covering all areas of infectious disease. Through our website, quarterly journal, email newsletters, social media outlets, and Outbreak Monitor we provide practitioners and specialists with disease-specific information designed to improve patient outcomes and assist with the identification, diagnosis, treatment, and prevention of infectious diseases. Our mission is to assure that the healthcare community and public have the knowledge to make more informed choices and have a positive impact on patient outcomes.
2 Clarke Drive
Cranbury, NJ 08512